Our Blog

Telix (ASX:TLX) collaborator awarded research grant

20 Dec 2019 – Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that Telix collaborator Professor Frédéric Hollande has been awarded a research grant for cancer research which is set to take place over 3 years.


Source: Finance News Network

Share this post